Dem Dx
- Company typePrivate
- Founded2015
- HeadquartersLondon, United Kingdom
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
Dem Dx firmographics
Firmographics- Name
- Dem Dx
- Legal name
- DemDX Limited
- Website
- https://demdx.com
- Company type
- Private
- Founded year
- 2015
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
Dem Dx industry classification
Industry- Product category
- Clinical Decision Support Software
- NAICS
- Custom Computer Programming Services (541511), Scientific Research and Development Services (5417)
- SIC
- Services-Prepackaged Software (7372), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- DTx/SaMD Deployment, Integration & Reimbursement Enablement (HLACANAO)
- akta.pro secondary industries
- DTx/SaMD Evidence, Outcomes & Real-World Data (RWE) Platforms (HLACANAM), Medication Therapy Management (MTM) & Clinical Pharmacy Services Tools (HLACAKAH)
Keywords
Where Dem Dx is headquartered
LocationHeadquarters
- HQ city
- London
- HQ country
- United Kingdom
- HQ region
- Europe
Offices1 record
Markets served
Dem Dx business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations
Revenue model
- SaaS Subscription Licensing: Subscription-based SaaS licensing model for NHS trusts, health boards, and healthcare organisations. Revenue generated through annual or multi-year contracts with healthcare institutions.
- Enterprise Platform Licensing: B2B enterprise licensing deals with NHS trusts and health systems, potentially including implementation and support services.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Freemium | Pay-as-you-go | 14-Day Free Trial |
| Subscription | Annual | NHS and Healthcare Organisations |
Go-to-market motion3 records
Distribution channels3 records
Marketing channels7 records
Dem Dx product offering
Product offeringCore offering
DemDx sells an AI-powered clinical reasoning platform that guides frontline healthcare professionals — nurses, allied health professionals (paramedics, physician associates, pharmacists, physiotherapists, optometrists), and community pharmacists — from a patient's presenting complaint through associated symptoms to differential diagnoses and management plans. The core platform is sold with vertical-specific solutions configured for primary care, community care, urgent care, secondary care, and pharmacy settings, plus a dedicated Ophthalmology Triage Platform co-developed with Moorfields Eye Hospital.
Product overview
DemDx is a unified AI-powered clinical reasoning platform designed to support frontline healthcare professionals (nurses, AHPs, pharmacists) in patient assessment and treatment decisions. The core DemDx Clinical Reasoning Platform serves as the foundation, with specialized solutions offered as tailored modules for different care settings: Primary Care, Community Care, Urgent Care, and Secondary Care. Pharmacy-specific offerings include the Pharmacy First Add-on and Minor Illness Add-on. A dedicated Ophthalmology Triage Platform was developed with Moorfields Eye Hospital for eye health services. All solutions share the same underlying platform architecture, evidence-based clinical pathways, and AI capabilities, but are configured with specialty-specific content and local protocols. The platform is accessible via web, tablet, and mobile devices as a standalone application or can be integrated with existing clinical systems.
Differentiator
Problem solved
Functional benefit
Products and services
- DemDx Clinical Reasoning Platform AI-powered clinical reasoning platform that supports patient assessment and treatment decisions by frontline healthcare professionals, guiding nurses, allied health professionals, and pharmacists from presenting complaints through symptoms to differential diagnoses and management plans using evidence-based clinical pathways.
- Primary Care Solution Clinical reasoning platform tailored for GP practices, extended access hubs, and home visiting services. Supports Additional Roles Reimbursement Scheme (ARRS) staff including nurses and AHPs to take on more clinical responsibility safely, free up GP time, and reduce inappropriate referrals.
- Community Care Solution Platform supporting community nurses and AHPs (paramedics, occupational therapists, pharmacists, physiotherapists, physician associates) to confidently assess and treat patients in community settings, reducing inappropriate hospital admissions and supporting multi-disciplinary rapid response, district nursing, and UTC teams.
- Urgent Care Solution Clinical reasoning platform for urgent care providers enabling nurses and AHPs to autonomously see, investigate, diagnose, treat and discharge patients with a broader range of conditions. Includes pathway-specific actions set by local clinical teams, supporting UTCs, A&E, ambulance crews, and out-of-hours services.
- Secondary Care Solution Hospital-focused clinical reasoning platform supporting nurses and AHPs to take on clinical responsibility, order tests, and make referrals. Covers 15 different specialties for assessment in secondary care settings, including urology and ophthalmology pilots.
- Pharmacy First Add-on Pharmacy-specific module for Pharmacy First consultations only, providing evidence-based pathways and automatic note generation to support community pharmacists in conducting safe, comprehensive consultations for minor ailments.
- Minor Illness Add-on Extended pharmacy module covering both Pharmacy First and Minor Illness consultations, offering comprehensive clinical support with evidence-based pathways and gold-standard note generation for community pharmacists.
- Ophthalmology Triage Platform AI-powered triage platform for eye health services developed in partnership with Moorfields Eye Hospital. Uses machine learning to help nurses and optometrists safely triage patients alongside NHS Attend Anywhere video consultations, with estimated potential to reduce unnecessary tertiary care referrals by up to 20%.
Quantifiable outcome
- 66% improvement in adherence to clinical guidelines
- +1 more outcomes
Companies that use Dem Dx
Customer profileNamed customers4 records
Segments4 records
Ideal customer profiles4 records
Dem Dx technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration2 records
AI capability6 records
Feature3 records
Dem Dx partnerships and signals
Strategic signalPartnerships
Eight partnerships are on record, tiered core and minor.
- Moorfields Eye Hospital NHS Foundation TrustcoreResearch partnership established in 2021 focused on ophthalmology clinical decision support. Dem Dx platform used to support clinical decision-making in eye care settings with Moorfields clinicians contributing to pathway development.
- Guy's and St Thomas' NHS Foundation TrustcoreUrology department pilot implementation of Dem Dx clinical decision support platform. Partnership focused on testing and validating platform capabilities in secondary care hospital setting.
- Bromley by Bow Health PartnershipcoreInnovate UK Biomedical Catalyst Grant partnership for community healthcare innovation. Primary care network piloting Dem Dx platform for community-based healthcare delivery.
- Homerton University Hospital NHS Foundation TrustcoreNHS trust implementation partnership for clinical decision support deployment across hospital services.
- Thanet CICminorSBRI Healthcare competition partnership for healthcare innovation project in Thanet region.
- University of RwandaminorGCRF (Global Challenges Research Fund) funded partnership for healthcare technology development and research collaboration.
- DigitalHealth.London AcceleratorcoreActive participation in DigitalHealth.London Accelerator programme providing NHS market access, mentorship, and credibility for NHS procurement.
- NHS Innovation AcceleratorcoreAccepted into NHS Innovation Accelerator programme supporting adoption of Dem Dx innovations across NHS trusts.
Scale indicators5 records
Recent moves6 records
Expansion highlights6 records
Dem Dx competitors and assessment
Company assessmentDirect peers
- BMJ Best Practice: BMJ's flagship clinical decision support tool used by clinicians globally to support diagnosis and treatment decisions. Direct competitor in the same clinician-facing evidence-based pathway category, with deeper specialty coverage and longer commercial track record.
- Isabel Healthcare: AI-powered differential diagnosis tool used by clinicians at the point of care. Closely comparable in clinical reasoning functionality and target user (physicians and frontline clinicians), with established presence in NHS and US hospital systems.
- VisualDx: Visual diagnostic decision support system combining AI image recognition with clinical knowledge. Comparable in being a clinician-facing CDSS with NHS deployment and differential diagnosis functionality, particularly relevant to Dem Dx's image modality and dermatology content.
Broad incumbents
- UpToDate (Wolters Kluwer): Industry-leading evidence-based clinical decision support resource used by the majority of US and many UK clinicians. A larger, established incumbent offering overlapping functionality as part of a broader portfolio, with greater content breadth and deeper EHR integrations.
- DynaMed (EBSCO): Evidence-based clinical decision support tool owned by EBSCO, used widely in hospitals and health systems. A larger incumbent with overlapping clinician-facing evidence-based pathway functionality, part of EBSCO's broader information services portfolio.
- Epic Systems: Dominant EHR vendor with embedded clinical decision support modules. A broad incumbent whose integrated CDS competes with standalone platforms like Dem Dx through tighter workflow embedding rather than specialised AHP-focused design.
Emerging players
- Ada Health: AI-powered symptom assessment and clinical reasoning platform with both consumer and enterprise offerings. Comparable AI clinical reasoning technology stack, with partial overlap in NHS pilots and differential diagnosis focus, though primarily consumer-led.
- Kahun: AI clinical reasoning platform that maps patient symptoms to evidence-based clinical knowledge. Comparable in AI-driven clinical reasoning and target clinician audience, at a similar early-stage scale with NHS and international pilots.
Regional players
- Health Navigator: UK-based clinical decision support and triage platform for NHS urgent and primary care pathways. Comparable in NHS focus and clinical reasoning for non-physician clinicians, with direct overlap in urgent care and primary care deployments.
Others
- Sophia Genetics: AI-driven clinical decision support focused on genomics and multimodal patient data, partnered with NHS trusts. An adjacent AI-health company with comparable NHS penetration and SaaS-to-clinician model, though operating in a different clinical specialty.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat6 records
Key risks7 records
Key highlights7 records
Customer concentration
Dem Dx social profiles
Digital presenceDem Dx compliance and trust
Trust signalCompliance5 records
Dem Dx financial estimates
Financial estimateRevenue estimate
Valuation estimate
Dem Dx leadership team
Management profileNumber of profiles
Profiles14 records
Dem Dx funding detail
Funding detailFunding overview
Funding rounds3 records
Investors3 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Dem Dx M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Dem Dx
What does Dem Dx do?
DemDx sells an AI-powered clinical reasoning platform that guides frontline healthcare professionals — nurses, allied health professionals (paramedics, physician associates, pharmacists, physiotherapists, optometrists), and community pharmacists — from a patient's presenting complaint through associated symptoms to differential diagnoses and management plans. The core platform is sold with vertical-specific solutions configured for primary care, community care, urgent care, secondary care, and pharmacy settings, plus a dedicated Ophthalmology Triage Platform co-developed with Moorfields Eye Hospital.
Is Dem Dx a public or private company?
Dem Dx is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Dem Dx founded?
Dem Dx was founded in 2015. It employs 11 to 50 people.
Where is Dem Dx based?
Dem Dx is headquartered in London, United Kingdom, in the Europe region.
How does Dem Dx make money?
Two revenue lines are on record. SaaS Subscription Licensing is the primary driver. The others are enterprise Platform Licensing.
Who are Dem Dx's main competitors?
Direct peers on record are BMJ Best Practice, Isabel Healthcare and VisualDx. Broad incumbents are UpToDate (Wolters Kluwer), DynaMed (EBSCO) and Epic Systems. Emerging players are Ada Health and Kahun. Health Navigator is listed as a regional player. Sophia Genetics is listed as an others.
Does Dem Dx have an API?
No public API is recorded for Dem Dx.
What industry is Dem Dx in?
Dem Dx's product category is Clinical Decision Support Software. Its primary akta.pro industry code is HLACANAO, DTx/SaMD Deployment, Integration & Reimbursement Enablement, with a secondary code of HLACANAM, DTx/SaMD Evidence, Outcomes & Real-World Data (RWE) Platforms. Its NAICS code is 541511 and its SIC code is 7372.